Plaque Psoriasis News
Psoriasis Linked to Higher Risk for Thyroid Disease
MONDAY, March 29, 2021 – Psoriasis is associated with an increased risk for thyroid disease among U.S. adults, according to research published online March 16 in the Journal of the American Academy...
Patients' Mental Health Impacts Rating of Psoriasis Severity
WEDNESDAY, March 3, 2021 – Discordance between patient and physician assessments of psoriasis severity is associated with patient depression and anxiety, according to a study published online March...
Prevalence Data Suggest Increasing Trend of Psoriasis With Age
MONDAY, Feb. 22, 2021 – A clear bimodal age pattern exists in psoriasis onset, and prevalence shows an increasing trend with age until 60 or 70 years, according to a review published in the February...
Overall Pregnancy, Live Birth Outcomes Unchanged in Psoriasis
WEDNESDAY, Feb. 17, 2021 – Overall pregnancy and live birth outcomes are similar for women with psoriasis and for the general population, according to a study published online Feb. 3 in JAMA...
Bimekizumab Superior to Ustekinumab for Plaque Psoriasis
FRIDAY, Feb. 5, 2021 – For moderate-to-severe plaque psoriasis, bimekizumab is more efficacious than ustekinumab and placebo, according to a study published in the Feb. 6 issue of The Lancet....
Some Inflammatory Diseases Linked to Stroke-Associated Pneumonia
THURSDAY, Jan. 28, 2021 – For patients discharged after acute ischemic stroke (AIS), the risk for stroke-associated pneumonia (SAP) is reduced for those with psoriasis or other chronic inflammatory...
Cardiorespiratory Fitness Linked to Psoriasis, Psoriatic Arthritis
FRIDAY, Jan. 15, 2021 – Low cardiovascular fitness in late adolescence is associated with an increased risk for incident psoriasis and psoriatic arthritis among men, according to a study published...
Patients With Psoriasis Shoulder Substantial Psychological Burden
MONDAY, Dec. 28, 2020 – Patients with psoriasis have a considerable psychological burden, according to a study published online Dec. 22 in The Journal of Dermatology. Wiebke Sondermann, M.D., from...
Adverse Pregnancy Outcomes Up for Women With Psoriasis
MONDAY, Nov. 30, 2020 – Pregnancies in women with psoriasis have an increased risk for adverse outcomes, including preeclampsia and stillbirth, according to a study published online Nov. 18 in the...
Risk for Bone Fractures Up for Patients With Psoriatic Diseases
MONDAY, Nov. 30, 2020 – For adults with psoriatic diseases, the likelihood of developing bone fractures is increased, although they have no increased risk for osteoporosis, according to a review...
Psoriasis Meds Don't Raise Risk of Severe COVID-19: Study
TUESDAY, Oct. 27, 2020 – Researchers in the United Kingdom have reassuring news for people with psoriasis based on the first analysis of a global registry of COVID-19 patients who also have the skin...
Survival From COVID-19 High in Patients With Psoriasis
FRIDAY, Oct. 23, 2020 – For patients with psoriasis, survival from COVID-19 is high, with increased hospitalization risk in association with nonbiologic systemic therapy versus biologic use,...
Lipid-Rich Necrotic Core Linked to Psoriasis Severity
TUESDAY, Sept. 15, 2020 – For patients with psoriasis, lipid-rich necrotic core (LRNC) is associated with psoriasis severity and cardiovascular risk factors and is reduced for those patients...
Some Psoriasis Meds May Also Help Prevent Heart Disease
TUESDAY, Sept. 15, 2020 – Biologic therapy for the skin condition psoriasis may reduce patients' risk of heart disease, new research suggests. Chronic inflammation in people with psoriasis is...
FDA Approves Stelara (ustekinumab) for Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
HORSHAM, Pa., July 30, 2020 /PRNewswire/ – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded...
Ask a Question
Want to post your own question to this support group? You'll need to first create an account with Drugs.com (or sign in to your existing account).
Further Information
Related Condition Support Groups
Related Drug Support Groups
methylprednisolone, Humira, Remicade, Enbrel, dexamethasone, Otezla, Stelara